Nature of Operations, Basis of Presentation and Liquidity (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
Nature of Operations, Basis of Presentation and Liquidity (Textual) | ||||||
Net loss | $ (815) | $ (921) | $ (2,452) | $ (3,071) | ||
Net revenues | 56 | 100 | ||||
Accumulated deficit | (41,777) | (41,777) | $ (39,325) | |||
Cash | 791 | $ 396 | 791 | 396 | 64 | $ 15 |
Working capital | 1,459 | 1,459 | ||||
Current assets | 2,313 | 2,313 | 1,758 | |||
Current liabilities | 854 | 854 | $ 1,712 | |||
Net cash used in/provided by operating activities | $ (2,211) | (1,904) | ||||
Ownership of shares, description | Under the exchange ratio formula in the Merger Agreement, as of immediately after the Merger, the former MedAvail security holders are expected to own approximately 96.5% of the aggregate number of fully-diluted shares of MYOS Common Stock outstanding following the consummation of the Merger (the "Post-Closing Shares"), and the stockholders of MYOS immediately prior to the Merger are expected to own approximately 3.5% of the Post-Closing Shares, subject to the adjustments set forth in the Merger Agreement. | |||||
Myos [Member] | ||||||
Nature of Operations, Basis of Presentation and Liquidity (Textual) | ||||||
Cash | 2,000 | $ 2,000 | ||||
Termination fee payable | 750,000 | |||||
Promissory note | $ 3,000 | 3,000 | ||||
MedAvail, Inc. [Member] | ||||||
Nature of Operations, Basis of Presentation and Liquidity (Textual) | ||||||
Termination fee payable | 500,000 | |||||
YOLKED [Member] | ||||||
Nature of Operations, Basis of Presentation and Liquidity (Textual) | ||||||
Net revenues | 176 | 229 | ||||
Myos Canine Muscle Formula [Member] | ||||||
Nature of Operations, Basis of Presentation and Liquidity (Textual) | ||||||
Net revenues | 853 | 282 | ||||
Physician Muscle Health Formula [Member] | ||||||
Nature of Operations, Basis of Presentation and Liquidity (Textual) | ||||||
Net revenues | $ 19 | $ 42 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Description of ownership of shares. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Termination fee payable. No definition available.
|
X | ||||||||||
- Definition Amount of working capital for the period. No definition available.
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|